Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 6.44133180 |
2 | locomotory exploration behavior (GO:0035641) | 6.30190928 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.17302567 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.67058367 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.56953669 |
6 | vocalization behavior (GO:0071625) | 5.49581410 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.30603687 |
8 | layer formation in cerebral cortex (GO:0021819) | 5.21663015 |
9 | synaptic vesicle exocytosis (GO:0016079) | 5.07643456 |
10 | glutamate secretion (GO:0014047) | 5.03059296 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.95520341 |
12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.92735831 |
13 | exploration behavior (GO:0035640) | 4.90035197 |
14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.89996741 |
15 | protein localization to synapse (GO:0035418) | 4.76312670 |
16 | regulation of synapse structural plasticity (GO:0051823) | 4.75406009 |
17 | dendritic spine morphogenesis (GO:0060997) | 4.65970860 |
18 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.55856724 |
19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.52450860 |
20 | L-amino acid import (GO:0043092) | 4.41742993 |
21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.41002147 |
22 | neuron cell-cell adhesion (GO:0007158) | 4.39871680 |
23 | regulation of synaptic vesicle transport (GO:1902803) | 4.35125919 |
24 | neurotransmitter secretion (GO:0007269) | 4.23273756 |
25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.11506514 |
26 | amino acid import (GO:0043090) | 4.05798308 |
27 | potassium ion homeostasis (GO:0055075) | 3.99458449 |
28 | proline transport (GO:0015824) | 3.98274209 |
29 | synaptic transmission, glutamatergic (GO:0035249) | 3.93919113 |
30 | axon ensheathment in central nervous system (GO:0032291) | 3.91868931 |
31 | central nervous system myelination (GO:0022010) | 3.91868931 |
32 | potassium ion import (GO:0010107) | 3.90727130 |
33 | positive regulation of synapse maturation (GO:0090129) | 3.87262251 |
34 | gamma-aminobutyric acid transport (GO:0015812) | 3.86978975 |
35 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.85371265 |
36 | dendrite morphogenesis (GO:0048813) | 3.82328104 |
37 | glutamate receptor signaling pathway (GO:0007215) | 3.78141373 |
38 | long-term memory (GO:0007616) | 3.77643689 |
39 | positive regulation of membrane potential (GO:0045838) | 3.75614163 |
40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74103794 |
41 | neuron recognition (GO:0008038) | 3.73771758 |
42 | activation of protein kinase A activity (GO:0034199) | 3.69884124 |
43 | neuronal action potential propagation (GO:0019227) | 3.68625595 |
44 | neuromuscular process controlling balance (GO:0050885) | 3.65949620 |
45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.61571304 |
46 | sodium ion export (GO:0071436) | 3.60648472 |
47 | neuron-neuron synaptic transmission (GO:0007270) | 3.58286083 |
48 | auditory behavior (GO:0031223) | 3.57794906 |
49 | cellular potassium ion homeostasis (GO:0030007) | 3.57306833 |
50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.56529895 |
51 | axonal fasciculation (GO:0007413) | 3.51729034 |
52 | regulation of synaptic plasticity (GO:0048167) | 3.47438797 |
53 | cellular sodium ion homeostasis (GO:0006883) | 3.46171004 |
54 | cell migration in hindbrain (GO:0021535) | 3.45829740 |
55 | postsynaptic membrane organization (GO:0001941) | 3.44714343 |
56 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.40980454 |
57 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.40284392 |
58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.39898850 |
59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37019753 |
60 | cell communication by electrical coupling (GO:0010644) | 3.35116375 |
61 | transmission of nerve impulse (GO:0019226) | 3.33119036 |
62 | neurotransmitter transport (GO:0006836) | 3.32879528 |
63 | dendritic spine organization (GO:0097061) | 3.32727539 |
64 | synaptic vesicle endocytosis (GO:0048488) | 3.30254407 |
65 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.29118168 |
66 | positive regulation of dendritic spine development (GO:0060999) | 3.27856891 |
67 | response to auditory stimulus (GO:0010996) | 3.27560211 |
68 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.25701270 |
69 | neuronal ion channel clustering (GO:0045161) | 3.25003890 |
70 | regulation of neurotransmitter secretion (GO:0046928) | 3.23941006 |
71 | regulation of dendritic spine development (GO:0060998) | 3.23298875 |
72 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.21315584 |
73 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.19843408 |
74 | prepulse inhibition (GO:0060134) | 3.18763842 |
75 | glycine transport (GO:0015816) | 3.17693873 |
76 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.15493569 |
77 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.15480353 |
78 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.15194762 |
79 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.14507555 |
80 | regulation of ARF protein signal transduction (GO:0032012) | 3.13702186 |
81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.13617924 |
82 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.11100517 |
83 | regulation of neurotransmitter levels (GO:0001505) | 3.10014525 |
84 | vesicle transport along microtubule (GO:0047496) | 3.09544120 |
85 | clathrin coat assembly (GO:0048268) | 3.09282916 |
86 | cerebellar Purkinje cell layer development (GO:0021680) | 3.08784201 |
87 | regulation of vesicle fusion (GO:0031338) | 3.07133299 |
88 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.05778491 |
89 | long-term synaptic potentiation (GO:0060291) | 3.03528207 |
90 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.02395928 |
91 | positive regulation of neurotransmitter transport (GO:0051590) | 3.00698545 |
92 | organelle transport along microtubule (GO:0072384) | 2.98560887 |
93 | regulation of neurotransmitter transport (GO:0051588) | 2.97383240 |
94 | innervation (GO:0060384) | 2.97175830 |
95 | learning (GO:0007612) | 2.95227074 |
96 | cell communication involved in cardiac conduction (GO:0086065) | 2.94621968 |
97 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94168593 |
98 | synapse assembly (GO:0007416) | 2.93634414 |
99 | dopamine receptor signaling pathway (GO:0007212) | 2.91251882 |
100 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.90642218 |
101 | social behavior (GO:0035176) | 2.90071453 |
102 | intraspecies interaction between organisms (GO:0051703) | 2.90071453 |
103 | regulation of synapse maturation (GO:0090128) | 2.89972803 |
104 | membrane depolarization (GO:0051899) | 2.89701528 |
105 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.89258761 |
106 | establishment of nucleus localization (GO:0040023) | 2.88349423 |
107 | behavioral fear response (GO:0001662) | 2.87950917 |
108 | behavioral defense response (GO:0002209) | 2.87950917 |
109 | membrane depolarization during action potential (GO:0086010) | 2.87891903 |
110 | neuromuscular process (GO:0050905) | 2.86074373 |
111 | membrane hyperpolarization (GO:0060081) | 2.84047470 |
112 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.83610993 |
113 | synapse organization (GO:0050808) | 2.83464099 |
114 | cerebellar granule cell differentiation (GO:0021707) | 2.83455301 |
115 | acidic amino acid transport (GO:0015800) | 2.82989926 |
116 | neurotransmitter uptake (GO:0001504) | 2.82665529 |
117 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.82132731 |
118 | establishment of mitochondrion localization (GO:0051654) | 2.78408902 |
119 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.76160857 |
120 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.75379462 |
121 | positive regulation of dendrite development (GO:1900006) | 2.74450117 |
122 | presynaptic membrane assembly (GO:0097105) | 2.71299387 |
123 | cellular response to catecholamine stimulus (GO:0071870) | 2.70875911 |
124 | cellular response to monoamine stimulus (GO:0071868) | 2.70875911 |
125 | presynaptic membrane organization (GO:0097090) | 2.70577860 |
126 | regulation of synaptic transmission (GO:0050804) | 2.69564406 |
127 | cell differentiation in hindbrain (GO:0021533) | 2.66773079 |
128 | detection of calcium ion (GO:0005513) | 2.65428343 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.59034014 |
2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07683034 |
3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.06172297 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05495673 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98843650 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.82899390 |
7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80145954 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80145954 |
9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.74743686 |
10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71771679 |
11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68516183 |
12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67205033 |
13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58214955 |
14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.57243822 |
15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55006979 |
16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53186738 |
17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48290345 |
18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46982605 |
19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.41296121 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.37417117 |
21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.31624364 |
22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.28627239 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.28427902 |
24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.24338391 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14822008 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.14603846 |
27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.10622221 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04716405 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89704874 |
30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85104668 |
31 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.77814033 |
32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72354928 |
33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64563011 |
34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60451053 |
35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48237936 |
36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47465364 |
37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.47387255 |
38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.47291140 |
39 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46383156 |
40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43768777 |
41 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42059648 |
42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40367323 |
43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36032231 |
44 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.34430586 |
45 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.32070927 |
46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31379135 |
47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31190461 |
48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31171664 |
49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30917970 |
50 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.28065032 |
51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27517767 |
52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26934713 |
53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26854684 |
54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24931543 |
55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22586606 |
56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21233926 |
57 | AR_19668381_ChIP-Seq_PC3_Human | 1.20431398 |
58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20343393 |
59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19436233 |
60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18783511 |
61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18688730 |
62 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18600082 |
63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12394496 |
64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11766618 |
65 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09793528 |
66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09571344 |
67 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07711945 |
68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06832063 |
69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06614646 |
70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06328471 |
71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05756107 |
72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05665431 |
73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05213611 |
74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05124343 |
75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03093393 |
76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02943005 |
77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02743915 |
78 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.01238442 |
79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01023425 |
80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00944969 |
81 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00377296 |
82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00210841 |
83 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00116604 |
84 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99979573 |
85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99342729 |
86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98762419 |
87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98211097 |
88 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97986084 |
89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97078107 |
90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96916587 |
91 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96204442 |
92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95938164 |
93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95763696 |
94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95660648 |
95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95480531 |
96 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94504503 |
97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94026362 |
98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93816636 |
99 | P68_20966046_ChIP-Seq_HELA_Human | 0.93482854 |
100 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.93190275 |
101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93115003 |
102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91776017 |
103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91671861 |
104 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90618018 |
105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90245416 |
106 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90190112 |
107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90082397 |
108 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89902248 |
109 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89730231 |
110 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88649524 |
111 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87599455 |
112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87106228 |
113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86134372 |
114 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85428040 |
115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85428040 |
116 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.85283388 |
117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.84447698 |
118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83946182 |
119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82913891 |
120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82303798 |
121 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81869561 |
122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81836318 |
123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81703727 |
124 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81379889 |
125 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81082994 |
126 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80675271 |
127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80294519 |
128 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.80054191 |
129 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.79926949 |
130 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79824066 |
131 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79664550 |
132 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79655119 |
133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.79635742 |
134 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79419734 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.37193863 |
2 | MP0003880_abnormal_central_pattern | 4.37507404 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.32179948 |
4 | MP0004270_analgesia | 4.10114287 |
5 | * MP0002063_abnormal_learning/memory/cond | 3.45679166 |
6 | MP0009745_abnormal_behavioral_response | 3.35164386 |
7 | MP0005423_abnormal_somatic_nervous | 3.14108742 |
8 | MP0002064_seizures | 3.05203713 |
9 | MP0002822_catalepsy | 2.78548550 |
10 | MP0001968_abnormal_touch/_nociception | 2.73387347 |
11 | MP0002734_abnormal_mechanical_nocicepti | 2.72333786 |
12 | MP0009046_muscle_twitch | 2.69846592 |
13 | * MP0002572_abnormal_emotion/affect_behav | 2.66806786 |
14 | MP0001486_abnormal_startle_reflex | 2.55570053 |
15 | MP0002272_abnormal_nervous_system | 2.37374947 |
16 | MP0000778_abnormal_nervous_system | 2.24935286 |
17 | MP0003329_amyloid_beta_deposits | 2.16795177 |
18 | MP0004858_abnormal_nervous_system | 2.14750667 |
19 | MP0001440_abnormal_grooming_behavior | 2.13786189 |
20 | MP0002733_abnormal_thermal_nociception | 2.10204823 |
21 | MP0002735_abnormal_chemical_nociception | 2.07255442 |
22 | MP0004811_abnormal_neuron_physiology | 2.01756669 |
23 | MP0002736_abnormal_nociception_after | 1.98521732 |
24 | MP0001501_abnormal_sleep_pattern | 1.95950237 |
25 | MP0001970_abnormal_pain_threshold | 1.95609447 |
26 | MP0008569_lethality_at_weaning | 1.95278427 |
27 | MP0002184_abnormal_innervation | 1.86234415 |
28 | MP0002909_abnormal_adrenal_gland | 1.84239328 |
29 | MP0000955_abnormal_spinal_cord | 1.76880312 |
30 | MP0002067_abnormal_sensory_capabilities | 1.76825242 |
31 | MP0004924_abnormal_behavior | 1.74670757 |
32 | MP0005386_behavior/neurological_phenoty | 1.74670757 |
33 | * MP0002557_abnormal_social/conspecific_i | 1.71336630 |
34 | * MP0002882_abnormal_neuron_morphology | 1.51421593 |
35 | * MP0002066_abnormal_motor_capabilities/c | 1.45728955 |
36 | MP0003633_abnormal_nervous_system | 1.37634032 |
37 | MP0000751_myopathy | 1.37139432 |
38 | MP0003787_abnormal_imprinting | 1.30199576 |
39 | MP0005646_abnormal_pituitary_gland | 1.29791091 |
40 | MP0003123_paternal_imprinting | 1.28727391 |
41 | * MP0004130_abnormal_muscle_cell | 1.28581107 |
42 | MP0006276_abnormal_autonomic_nervous | 1.25931388 |
43 | * MP0002152_abnormal_brain_morphology | 1.23608536 |
44 | MP0001984_abnormal_olfaction | 1.23446161 |
45 | MP0000569_abnormal_digit_pigmentation | 1.21704317 |
46 | MP0003631_nervous_system_phenotype | 1.17187068 |
47 | MP0003283_abnormal_digestive_organ | 1.15443909 |
48 | MP0003705_abnormal_hypodermis_morpholog | 1.14612682 |
49 | MP0005645_abnormal_hypothalamus_physiol | 1.13065983 |
50 | MP0001502_abnormal_circadian_rhythm | 1.10974660 |
51 | * MP0004885_abnormal_endolymph | 1.10135846 |
52 | MP0001905_abnormal_dopamine_level | 1.06391890 |
53 | MP0001177_atelectasis | 1.06385335 |
54 | MP0003634_abnormal_glial_cell | 1.04990156 |
55 | MP0008961_abnormal_basal_metabolism | 1.04264773 |
56 | MP0000920_abnormal_myelination | 1.02592209 |
57 | MP0003690_abnormal_glial_cell | 1.02434728 |
58 | MP0003075_altered_response_to | 1.01351107 |
59 | MP0002249_abnormal_larynx_morphology | 0.99742138 |
60 | MP0005670_abnormal_white_adipose | 0.99382018 |
61 | MP0004142_abnormal_muscle_tone | 0.97415697 |
62 | MP0001529_abnormal_vocalization | 0.96732930 |
63 | MP0000604_amyloidosis | 0.96443463 |
64 | * MP0002069_abnormal_eating/drinking_beha | 0.93150338 |
65 | MP0002229_neurodegeneration | 0.92457891 |
66 | MP0003122_maternal_imprinting | 0.92027902 |
67 | MP0004145_abnormal_muscle_electrophysio | 0.91898174 |
68 | MP0000749_muscle_degeneration | 0.90437653 |
69 | MP0005623_abnormal_meninges_morphology | 0.89641931 |
70 | MP0003632_abnormal_nervous_system | 0.87916454 |
71 | MP0001958_emphysema | 0.87065871 |
72 | MP0008874_decreased_physiological_sensi | 0.86999591 |
73 | MP0000013_abnormal_adipose_tissue | 0.85828808 |
74 | MP0004742_abnormal_vestibular_system | 0.82854589 |
75 | * MP0003879_abnormal_hair_cell | 0.82550724 |
76 | MP0005167_abnormal_blood-brain_barrier | 0.81740630 |
77 | MP0002638_abnormal_pupillary_reflex | 0.81668541 |
78 | * MP0004085_abnormal_heartbeat | 0.81548178 |
79 | MP0008872_abnormal_physiological_respon | 0.81102345 |
80 | MP0004036_abnormal_muscle_relaxation | 0.78728914 |
81 | MP0002090_abnormal_vision | 0.78721929 |
82 | MP0000759_abnormal_skeletal_muscle | 0.78551837 |
83 | MP0004233_abnormal_muscle_weight | 0.78155143 |
84 | MP0005499_abnormal_olfactory_system | 0.76541094 |
85 | MP0005394_taste/olfaction_phenotype | 0.76541094 |
86 | MP0004147_increased_porphyrin_level | 0.76411867 |
87 | MP0005187_abnormal_penis_morphology | 0.76296798 |
88 | MP0001348_abnormal_lacrimal_gland | 0.75856771 |
89 | MP0004215_abnormal_myocardial_fiber | 0.75822696 |
90 | MP0004510_myositis | 0.74710621 |
91 | MP0004087_abnormal_muscle_fiber | 0.73775877 |
92 | * MP0003861_abnormal_nervous_system | 0.72935824 |
93 | MP0010234_abnormal_vibrissa_follicle | 0.72459715 |
94 | * MP0002752_abnormal_somatic_nervous | 0.72240748 |
95 | MP0002837_dystrophic_cardiac_calcinosis | 0.70697467 |
96 | MP0005551_abnormal_eye_electrophysiolog | 0.70280316 |
97 | MP0001299_abnormal_eye_distance/ | 0.69608105 |
98 | MP0004484_altered_response_of | 0.68143350 |
99 | MP0002234_abnormal_pharynx_morphology | 0.67577590 |
100 | MP0001188_hyperpigmentation | 0.66987007 |
101 | MP0005666_abnormal_adipose_tissue | 0.66231452 |
102 | MP0002971_abnormal_brown_adipose | 0.65031165 |
103 | * MP0003137_abnormal_impulse_conducting | 0.63516800 |
104 | * MP0001963_abnormal_hearing_physiology | 0.63206990 |
105 | MP0003172_abnormal_lysosome_physiology | 0.62565940 |
106 | MP0003045_fibrosis | 0.62225008 |
107 | * MP0005535_abnormal_body_temperature | 0.62081797 |
108 | MP0005166_decreased_susceptibility_to | 0.61612930 |
109 | MP0005409_darkened_coat_color | 0.61516736 |
110 | * MP0000631_abnormal_neuroendocrine_gland | 0.61296778 |
111 | MP0001346_abnormal_lacrimal_gland | 0.59568201 |
112 | MP0002089_abnormal_postnatal_growth/wei | 0.59289596 |
113 | MP0001485_abnormal_pinna_reflex | 0.58579125 |
114 | MP0001943_abnormal_respiration | 0.57478402 |
115 | MP0000747_muscle_weakness | 0.57346591 |
116 | MP0001664_abnormal_digestion | 0.57228061 |
117 | MP0002106_abnormal_muscle_physiology | 0.56978506 |
118 | MP0010386_abnormal_urinary_bladder | 0.56566986 |
119 | MP0003279_aneurysm | 0.56498411 |
120 | MP0005375_adipose_tissue_phenotype | 0.55420434 |
121 | MP0003183_abnormal_peptide_metabolism | 0.55186045 |
122 | * MP0010769_abnormal_survival | 0.52963560 |
123 | MP0005388_respiratory_system_phenotype | 0.51267475 |
124 | MP0002133_abnormal_respiratory_system | 0.51267475 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 7.05283806 |
2 | Focal motor seizures (HP:0011153) | 5.97859605 |
3 | Visual hallucinations (HP:0002367) | 5.07429974 |
4 | Focal seizures (HP:0007359) | 4.98528357 |
5 | Supranuclear gaze palsy (HP:0000605) | 4.12076320 |
6 | Epileptic encephalopathy (HP:0200134) | 4.04436548 |
7 | Ankle clonus (HP:0011448) | 3.98180254 |
8 | Action tremor (HP:0002345) | 3.87135058 |
9 | Mutism (HP:0002300) | 3.80006222 |
10 | Progressive cerebellar ataxia (HP:0002073) | 3.70435470 |
11 | Papilledema (HP:0001085) | 3.61512525 |
12 | Poor eye contact (HP:0000817) | 3.45050244 |
13 | Atonic seizures (HP:0010819) | 3.31061059 |
14 | Broad-based gait (HP:0002136) | 3.29820188 |
15 | Depression (HP:0000716) | 3.24403065 |
16 | Generalized tonic-clonic seizures (HP:0002069) | 3.23969068 |
17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.21551080 |
18 | Febrile seizures (HP:0002373) | 3.20591711 |
19 | Absence seizures (HP:0002121) | 3.20557320 |
20 | Neurofibrillary tangles (HP:0002185) | 3.18658813 |
21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.17506289 |
22 | Impaired social interactions (HP:0000735) | 3.10809780 |
23 | Abnormal social behavior (HP:0012433) | 3.10809780 |
24 | Torticollis (HP:0000473) | 3.09252032 |
25 | Cerebral inclusion bodies (HP:0100314) | 3.08505336 |
26 | Megalencephaly (HP:0001355) | 3.05117680 |
27 | Abnormality of the lower motor neuron (HP:0002366) | 3.04400521 |
28 | Urinary urgency (HP:0000012) | 2.94566108 |
29 | Peripheral hypomyelination (HP:0007182) | 2.94387449 |
30 | Postural instability (HP:0002172) | 2.90633477 |
31 | Dialeptic seizures (HP:0011146) | 2.89982050 |
32 | Abnormal eating behavior (HP:0100738) | 2.89973727 |
33 | Anxiety (HP:0000739) | 2.88320636 |
34 | Dysdiadochokinesis (HP:0002075) | 2.83335536 |
35 | Focal dystonia (HP:0004373) | 2.82356446 |
36 | Amyotrophic lateral sclerosis (HP:0007354) | 2.81825602 |
37 | Abnormality of the corticospinal tract (HP:0002492) | 2.81679719 |
38 | Dysmetria (HP:0001310) | 2.81508341 |
39 | Genetic anticipation (HP:0003743) | 2.76186738 |
40 | Spastic gait (HP:0002064) | 2.72682504 |
41 | Excessive salivation (HP:0003781) | 2.70865319 |
42 | Drooling (HP:0002307) | 2.70865319 |
43 | Obstructive sleep apnea (HP:0002870) | 2.70696591 |
44 | Insomnia (HP:0100785) | 2.69621286 |
45 | Gaze-evoked nystagmus (HP:0000640) | 2.67517511 |
46 | Intention tremor (HP:0002080) | 2.66245629 |
47 | Insidious onset (HP:0003587) | 2.65361516 |
48 | Termporal pattern (HP:0011008) | 2.65361516 |
49 | Amblyopia (HP:0000646) | 2.63447271 |
50 | Hyporeflexia of lower limbs (HP:0002600) | 2.61916595 |
51 | Limb dystonia (HP:0002451) | 2.59375679 |
52 | Hemiparesis (HP:0001269) | 2.56206699 |
53 | Craniofacial dystonia (HP:0012179) | 2.55391532 |
54 | Truncal ataxia (HP:0002078) | 2.54876217 |
55 | Ventricular fibrillation (HP:0001663) | 2.54374296 |
56 | Progressive inability to walk (HP:0002505) | 2.52120824 |
57 | Tetraplegia (HP:0002445) | 2.50034384 |
58 | Stereotypic behavior (HP:0000733) | 2.49881686 |
59 | Abnormality of binocular vision (HP:0011514) | 2.48515559 |
60 | Diplopia (HP:0000651) | 2.48515559 |
61 | Exercise-induced myalgia (HP:0003738) | 2.47349296 |
62 | Lower limb muscle weakness (HP:0007340) | 2.41184346 |
63 | Bradykinesia (HP:0002067) | 2.37011525 |
64 | Pointed chin (HP:0000307) | 2.36879188 |
65 | Hyperventilation (HP:0002883) | 2.35450178 |
66 | Turricephaly (HP:0000262) | 2.29408544 |
67 | Apathy (HP:0000741) | 2.29261032 |
68 | Annular pancreas (HP:0001734) | 2.28995917 |
69 | Hemiplegia (HP:0002301) | 2.28762179 |
70 | Akinesia (HP:0002304) | 2.26964542 |
71 | Cerebral hypomyelination (HP:0006808) | 2.26518486 |
72 | Foot dorsiflexor weakness (HP:0009027) | 2.25853908 |
73 | Impaired smooth pursuit (HP:0007772) | 2.22664262 |
74 | Bundle branch block (HP:0011710) | 2.20995608 |
75 | Polyphagia (HP:0002591) | 2.19033058 |
76 | Muscle fiber splitting (HP:0003555) | 2.18489905 |
77 | Type 1 muscle fiber predominance (HP:0003803) | 2.18328753 |
78 | Fetal akinesia sequence (HP:0001989) | 2.18190364 |
79 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17649651 |
80 | Epileptiform EEG discharges (HP:0011182) | 2.17075375 |
81 | Inappropriate behavior (HP:0000719) | 2.15858516 |
82 | Hypsarrhythmia (HP:0002521) | 2.15723429 |
83 | Shallow orbits (HP:0000586) | 2.14208714 |
84 | Scanning speech (HP:0002168) | 2.11494506 |
85 | Abnormality of the foot musculature (HP:0001436) | 2.10935737 |
86 | Clonus (HP:0002169) | 2.09555679 |
87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09466727 |
88 | Increased circulating renin level (HP:0000848) | 2.09125669 |
89 | Lower limb amyotrophy (HP:0007210) | 2.09094243 |
90 | Agitation (HP:0000713) | 2.07144687 |
91 | Impaired vibratory sensation (HP:0002495) | 2.05873762 |
92 | Heart block (HP:0012722) | 2.03574502 |
93 | Diminished motivation (HP:0000745) | 2.01230429 |
94 | Sudden death (HP:0001699) | 2.00775457 |
95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99859776 |
96 | Pheochromocytoma (HP:0002666) | 1.99820177 |
97 | Rapidly progressive (HP:0003678) | 1.98951536 |
98 | Aplasia involving bones of the extremities (HP:0009825) | 1.98850462 |
99 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.98850462 |
100 | Aplasia of the phalanges of the hand (HP:0009802) | 1.98850462 |
101 | Difficulty running (HP:0009046) | 1.98511932 |
102 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.98151862 |
103 | Dysmetric saccades (HP:0000641) | 1.96178612 |
104 | Abnormal atrioventricular conduction (HP:0005150) | 1.96102456 |
105 | Bronchomalacia (HP:0002780) | 1.95717905 |
106 | Delusions (HP:0000746) | 1.92251767 |
107 | Prolonged QT interval (HP:0001657) | 1.90989765 |
108 | Ankyloglossia (HP:0010296) | 1.90607818 |
109 | Neuronal loss in central nervous system (HP:0002529) | 1.90448930 |
110 | Spinal canal stenosis (HP:0003416) | 1.90243150 |
111 | Lower limb asymmetry (HP:0100559) | 1.89065236 |
112 | Absent speech (HP:0001344) | 1.89035648 |
113 | Abnormal EKG (HP:0003115) | 1.88209279 |
114 | Generalized myoclonic seizures (HP:0002123) | 1.86762822 |
115 | Hyperacusis (HP:0010780) | 1.85921702 |
116 | Hypoplasia of the brainstem (HP:0002365) | 1.85046621 |
117 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.85046621 |
118 | Inability to walk (HP:0002540) | 1.84744759 |
119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.81511195 |
120 | Hypercortisolism (HP:0001578) | 1.81209946 |
121 | Cerebral aneurysm (HP:0004944) | 1.79393753 |
122 | Bowel incontinence (HP:0002607) | 1.79222067 |
123 | Slow progression (HP:0003677) | 1.78327205 |
124 | Atrioventricular block (HP:0001678) | 1.78026269 |
125 | Sleep apnea (HP:0010535) | 1.77645391 |
126 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77515457 |
127 | Intellectual disability, profound (HP:0002187) | 1.77500521 |
128 | Pachygyria (HP:0001302) | 1.77080824 |
129 | Status epilepticus (HP:0002133) | 1.76828516 |
130 | Rigidity (HP:0002063) | 1.76208355 |
131 | Aqueductal stenosis (HP:0002410) | 1.75827995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MARK1 | 4.83143265 |
2 | MAP3K9 | 4.04728809 |
3 | EPHA4 | 3.93281513 |
4 | NTRK3 | 3.65177041 |
5 | MINK1 | 2.77726014 |
6 | DAPK2 | 2.58685901 |
7 | MAP3K4 | 2.56955254 |
8 | PAK6 | 2.48331314 |
9 | PRKD3 | 2.39909208 |
10 | KSR2 | 2.29196706 |
11 | NTRK2 | 2.19203092 |
12 | CAMKK1 | 2.07989914 |
13 | MAP2K7 | 1.95535303 |
14 | NTRK1 | 1.83089310 |
15 | KSR1 | 1.71447535 |
16 | PHKG1 | 1.71419727 |
17 | PHKG2 | 1.71419727 |
18 | CDK5 | 1.61720369 |
19 | TYRO3 | 1.57343307 |
20 | MAP2K4 | 1.51751789 |
21 | SIK2 | 1.51320126 |
22 | LATS2 | 1.48069697 |
23 | MAPK13 | 1.41221563 |
24 | TAOK1 | 1.32024119 |
25 | TNIK | 1.29624514 |
26 | DAPK1 | 1.27144984 |
27 | MAP3K2 | 1.25321354 |
28 | STK38 | 1.21992652 |
29 | PRPF4B | 1.19432089 |
30 | UHMK1 | 1.17242854 |
31 | PLK2 | 1.12451313 |
32 | GRK5 | 1.10914204 |
33 | MAP3K12 | 1.10289460 |
34 | PRKCG | 1.09481375 |
35 | CDK19 | 1.05142470 |
36 | FES | 1.02937722 |
37 | LMTK2 | 1.02868901 |
38 | CAMK2G | 1.00592205 |
39 | STK11 | 0.99327300 |
40 | RET | 0.98713371 |
41 | ARAF | 0.96708040 |
42 | CDK15 | 0.96563230 |
43 | CDK18 | 0.95701345 |
44 | ALK | 0.95225056 |
45 | CDK14 | 0.94490587 |
46 | RIPK4 | 0.94443541 |
47 | MARK2 | 0.93315540 |
48 | PRKCH | 0.92982790 |
49 | NEK6 | 0.91476037 |
50 | TNK2 | 0.88591983 |
51 | PAK3 | 0.88471600 |
52 | EEF2K | 0.88188822 |
53 | CSNK1G2 | 0.86879012 |
54 | CAMK1 | 0.86058265 |
55 | PNCK | 0.85623954 |
56 | CDK11A | 0.84703369 |
57 | RIPK1 | 0.84496866 |
58 | CAMKK2 | 0.80376265 |
59 | CAMK2A | 0.79042278 |
60 | OBSCN | 0.77670969 |
61 | SGK494 | 0.76174161 |
62 | SGK223 | 0.76174161 |
63 | MAP3K13 | 0.74486617 |
64 | TRIB3 | 0.73577656 |
65 | TTN | 0.72627400 |
66 | RAF1 | 0.72584867 |
67 | DYRK1A | 0.71398148 |
68 | ROCK2 | 0.69129520 |
69 | CASK | 0.66515553 |
70 | PRKCZ | 0.66419544 |
71 | CAMK2D | 0.65752313 |
72 | PINK1 | 0.65741665 |
73 | PDK1 | 0.65554009 |
74 | DYRK2 | 0.64298186 |
75 | PTK2B | 0.64192448 |
76 | PDPK1 | 0.63031040 |
77 | SIK1 | 0.62671325 |
78 | DMPK | 0.62053205 |
79 | ICK | 0.61498146 |
80 | SCYL2 | 0.60363955 |
81 | SGK1 | 0.60084936 |
82 | CAMK2B | 0.58887303 |
83 | WNK1 | 0.58577184 |
84 | MAP3K11 | 0.57759287 |
85 | CAMK1G | 0.57593427 |
86 | ERBB3 | 0.57454430 |
87 | ROCK1 | 0.56654639 |
88 | PKN1 | 0.55736195 |
89 | FYN | 0.55447793 |
90 | CDK12 | 0.54853200 |
91 | TESK1 | 0.54527238 |
92 | SGK3 | 0.54032682 |
93 | OXSR1 | 0.53766553 |
94 | DDR2 | 0.51693088 |
95 | NEK1 | 0.50860096 |
96 | FGFR2 | 0.50272418 |
97 | MAPK4 | 0.50042086 |
98 | RPS6KA2 | 0.48155723 |
99 | CAMK1D | 0.47643906 |
100 | MAP3K1 | 0.47261419 |
101 | CDC42BPA | 0.47075038 |
102 | MAP3K7 | 0.46944915 |
103 | BRSK1 | 0.45458951 |
104 | LIMK1 | 0.44989135 |
105 | * RPS6KA3 | 0.44794095 |
106 | PRKG2 | 0.43995725 |
107 | DAPK3 | 0.43720070 |
108 | MAPK12 | 0.43587014 |
109 | ERBB2 | 0.43229795 |
110 | PRKD1 | 0.43159212 |
111 | SGK2 | 0.43145161 |
112 | PDGFRA | 0.41350980 |
113 | PRKCE | 0.40425785 |
114 | CAMK4 | 0.39762296 |
115 | BRAF | 0.39097817 |
116 | MAPK10 | 0.38821859 |
117 | PKN2 | 0.37674402 |
118 | MAP3K6 | 0.37513242 |
119 | MAP2K1 | 0.35370413 |
120 | CSNK1G3 | 0.32638801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.00547246 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.95318919 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.70264097 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60734371 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.51625781 |
6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.47852998 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.46726621 |
8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34864565 |
9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30096187 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.29972343 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.19896967 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11474169 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 2.02323179 |
14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98426767 |
15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90606139 |
16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85186209 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.84667591 |
18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77756231 |
19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65909058 |
20 | Renin secretion_Homo sapiens_hsa04924 | 1.60160594 |
21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59483688 |
22 | Long-term depression_Homo sapiens_hsa04730 | 1.59482497 |
23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.59352030 |
24 | Gap junction_Homo sapiens_hsa04540 | 1.49886921 |
25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49331580 |
26 | Axon guidance_Homo sapiens_hsa04360 | 1.47035102 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42558778 |
28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.42484052 |
29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40244057 |
30 | Taste transduction_Homo sapiens_hsa04742 | 1.37121813 |
31 | Glioma_Homo sapiens_hsa05214 | 1.33885334 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33201063 |
33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27309391 |
34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.26161824 |
35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26087194 |
36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26018185 |
37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.16539348 |
38 | Melanogenesis_Homo sapiens_hsa04916 | 1.11524434 |
39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11174927 |
40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08785209 |
41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05722345 |
42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03414180 |
43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02123802 |
44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98051024 |
45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95974351 |
46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95515657 |
47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91548813 |
48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90693960 |
49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90517262 |
50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85793020 |
51 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85687050 |
52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83205273 |
53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82822726 |
54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81371168 |
55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80905516 |
56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79968542 |
57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76968671 |
58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76199272 |
59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75350446 |
60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73448952 |
61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73152298 |
62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71501840 |
63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70576515 |
64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69887224 |
65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67695477 |
66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67056640 |
67 | Endocytosis_Homo sapiens_hsa04144 | 0.66720126 |
68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65820819 |
69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65314021 |
70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65220363 |
71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63515479 |
72 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63347985 |
73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62333953 |
74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60365371 |
75 | Phototransduction_Homo sapiens_hsa04744 | 0.59264790 |
76 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58490305 |
77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57489796 |
78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57158862 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56645841 |
80 | Bile secretion_Homo sapiens_hsa04976 | 0.56380150 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55832821 |
82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55687121 |
83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55679588 |
84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54230314 |
85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52382694 |
86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51999968 |
87 | Alcoholism_Homo sapiens_hsa05034 | 0.51243279 |
88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49989036 |
89 | Prion diseases_Homo sapiens_hsa05020 | 0.49897803 |
90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49871836 |
91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49065979 |
92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47577715 |
93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47270647 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45733545 |
95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45353186 |
96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41808085 |
97 | Focal adhesion_Homo sapiens_hsa04510 | 0.41720604 |
98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41500527 |
99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40885214 |
100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40687317 |
101 | Tight junction_Homo sapiens_hsa04530 | 0.40654200 |
102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40315882 |
103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39605168 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39604782 |
105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38242965 |
106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38028440 |
107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37479704 |
108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35092373 |
109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34873658 |
110 | Platelet activation_Homo sapiens_hsa04611 | 0.34037807 |
111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33311473 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31070407 |
113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30668324 |
114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30152750 |